Cargando…
Tumor pyruvate kinase M2: A promising molecular target of gastrointestinal cancer
Gastrointestinal (GI) cancer is one of the most common causes of cancer-related deaths worldwide. Tumor markers are valuable in detecting post-surgical recurrence or in monitoring response to chemotherapy. Pyruvate kinase isoform M2 (PKM2), a glycolytic enzyme catalyzing conversion of phosphoenolpyr...
Autores principales: | Guo, Chen, Li, Guan, Hou, Jianing, Deng, Xingming, Ao, Sheng, Li, Zhuofei, Lyu, Guoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328500/ https://www.ncbi.nlm.nih.gov/pubmed/30700935 http://dx.doi.org/10.21147/j.issn.1000-9604.2018.06.11 |
Ejemplares similares
-
Prognostic significance of periostin in colorectal cancer
por: Deng, Xingming, et al.
Publicado: (2019) -
Mutations in ALK and TSC1 in a gastrointestinal stromal tumor: a case report
por: Song, Qingzhi, et al.
Publicado: (2021) -
Comparison of Microbiota in Patients Treated by Surgery or Chemotherapy by 16S rRNA Sequencing Reveals Potential Biomarkers for Colorectal Cancer Therapy
por: Deng, Xingming, et al.
Publicado: (2018) -
Low expression of miR-125a-5p is associated with poor prognosis in patients with gastric cancer
por: Li, Guan, et al.
Publicado: (2019) -
Pyruvate kinase isozyme M2 and glutaminase might be promising molecular targets for the treatment of gastric cancer
por: Kitayama, Kishu, et al.
Publicado: (2017)